Literature DB >> 22673728

Large prostate motion produced by anal contraction.

Hiroshi Onishi1, Kengo Kuriyama, Takafumi Komiyama, Kan Marino, Masayuki Araya, Ryo Saito, Shinichi Aoki, Yoshiyasu Maehata, Licht Tominaga, Naoki Sano, Mitsuhiko Oguri, Kojiro Onohara, Iori Watanabe, Tsuyota Koshiishi, Kazuhiko Ogawa, Tsutomu Araki.   

Abstract

BACKGROUND AND
PURPOSE: The aim of this study was to define the effects of voluntary anal contraction on prostate motion in an experimental setting.
MATERIALS AND METHODS: Thirty-eight patients (median age, 76 years) with prostate cancer underwent thin-slice computed tomography (CT) in the vicinity of the prostate before and after active anal contraction. Three-dimensional displacement of the pelvis and prostate was measured.
RESULTS: Mean (±standard deviation, SD) overall displacement of the prostate due to anal contraction was 0.3±1.4 mm to the right, 9.3±7.8 mm to the anterior, and 5±4 mm to the cranial direction. Mean displacement of the pelvis was 0.5±1.8 mm to the right, 4.1±7.1 mm to the anterior, and 1±3 mm to the cranial direction. Mean displacement of the prostate relative to the pelvis was 0.1±1.1 mm to the left, 5.2±3.3 mm to the anterior, and 4±4 mm to the cranial direction.
CONCLUSIONS: Voluntary anal contraction within an experimental setting induces large prostate and bone motion, mainly in the anterior and cranial directions. The frequency and magnitude of actual anal contractions during radiotherapy for prostate cancer need to be determined.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22673728     DOI: 10.1016/j.radonc.2012.04.005

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

1.  Reduction of rectal doses by removal of gas in the rectum during vaginal cuff brachytherapy.

Authors:  S Sabater; Ma M Sevillano; I Andres; R Berenguer; S Machin-Hamalainen; K Müller; M Arenas
Journal:  Strahlenther Onkol       Date:  2013-09-04       Impact factor: 3.621

2.  The impact of androgen deprivation therapy on setup errors during external beam radiation therapy for prostate cancer.

Authors:  Cem Onal; Yemliha Dolek; Yurday Ozdemir
Journal:  Strahlenther Onkol       Date:  2017-04-13       Impact factor: 3.621

3.  Dose impact of rectal gas on prostatic IMRT and VMAT.

Authors:  Motoharu Sasaki; Hitoshi Ikushima; Masahide Tominaga; Takeshi Kamomae; Taro Kishi; Masataka Oita; Masafumi Harada
Journal:  Jpn J Radiol       Date:  2015-11-17       Impact factor: 2.374

4.  Dose/volume-response relations for rectal morbidity using planned and simulated motion-inclusive dose distributions.

Authors:  Maria Thor; Aditya Apte; Joseph O Deasy; Àsa Karlsdóttir; Vitali Moiseenko; Mitchell Liu; Ludvig Paul Muren
Journal:  Radiother Oncol       Date:  2013-11-11       Impact factor: 6.280

5.  A comparative study of high-dose-rate brachytherapy boost combined with external beam radiation therapy versus external beam radiation therapy alone for high-risk prostate cancer.

Authors:  Tomoya Oshikane; Motoki Kaidu; Eisuke Abe; Atsushi Ohta; Hirotake Saito; Toshimichi Nakano; Moe Honda; Satoshi Tanabe; Satoru Utsunomiya; Ryuta Sasamoto; Fumio Ishizaki; Takashi Kasahara; Tsutomu Nishiyama; Yoshihiko Tomita; Hidefumi Aoyama; Hiroyuki Ishikawa
Journal:  J Radiat Res       Date:  2021-05-12       Impact factor: 2.724

6.  The effect of rectal gas on dose distribution during prostate cancer treatment using full arc and partial arc Volumetric Modulated Arc Therapy (VMAT) treatment plans.

Authors:  Motoharu Sasaki; Hitoshi Ikushima; Akira Tsuzuki; Wataru Sugimoto
Journal:  Rep Pract Oncol Radiother       Date:  2020-10-11

7.  Evaluation of different set-up error corrections on dose-volume metrics in prostate IMRT using CBCT images.

Authors:  Yoshinori Hirose; Mitsuhiro Nakamura; Tsuneyuki Tomita; Kenji Kitsuda; Takuya Notogawa; Katsuhito Miki; Kiyonao Nakamura; Takashi Ishigaki
Journal:  J Radiat Res       Date:  2014-05-12       Impact factor: 2.724

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.